Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 21
Posts 1,504
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/22/2014 4:21:22 PM
NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT "PR Newswire (US)" - 7/16/2014 8:15:00 AM
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securi... "PR Newswire (US)" - 7/9/2014 6:23:00 PM
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, I... "PR Newswire (US)" - 7/4/2014 1:17:00 PM
Investigation of Northwest Biotherapeutics, Inc. Announced by Glancy Binkow & Goldberg LLP "Business Wire" - 7/1/2014 5:32:00 PM
Robbins Arroyo LLP Is Investigating the Officers and Directors of Northwest Biotherapeutics, Inc. on Behalf of Shareholders "PR Newswire (US)" - 7/1/2014 1:33:00 PM
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securi... "Business Wire" - 6/25/2014 4:50:00 PM
NW BIO REAFFIRMS DCVAX®-DIRECT CLINICAL TRIAL INTERIM DATA ANNOUNCEMENTS "PR Newswire (US)" - 6/20/2014 8:25:00 AM
Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G.... "Business Wire" - 6/19/2014 4:32:00 PM
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Northwest Biotherapeutics, Inc. "PR Newswire (US)" - 6/19/2014 2:30:00 PM
Investor Alert: Investigation into Northwest Biotherapeutics, Inc. Announced by Holzer & Holzer, LLC "Business Wire" - 6/19/2014 2:11:00 PM
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO "PR Newswire (US)" - 6/19/2014 11:16:00 AM
NW BIO NAMED TO TWO RUSSELL INDEXES "PR Newswire (US)" - 6/16/2014 8:15:00 AM
DCVAX-DIRECT TRIAL UPDATE INDICATES FURTHER POSITIVE RESPONSES; 3 CASE STUDIES SHOW NO LIVE TUMOR CELLS IN INJECTED TUMORS "PR Newswire (US)" - 6/11/2014 8:15:00 AM
DCVAX®-L PHASE III TRIAL INITIATED IN GERMANY "PR Newswire (US)" - 6/10/2014 8:15:00 AM
NW BIO TO PRESENT AT JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE "PR Newswire (US)" - 6/4/2014 11:23:00 AM
NW BIO REFUTES MORE FALSE CLAIMS BY FEUERSTEIN "PR Newswire (US)" - 5/29/2014 9:27:00 AM
NW BIO TO HOLD CONFERENCE CALL TO DISCUSS EARLY RESULTS OF DCVAX®-DIRECT ONGOING PHASE I/II TRIAL "PR Newswire (US)" - 5/27/2014 12:05:00 PM
EARLY POSITIVE RESPONSES SEEN IN OVER 50% OF DCVAX®-DIRECT PATIENTS TO DATE "PR Newswire (US)" - 5/27/2014 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2014 5:12:16 PM
NW BIO ANNOUNCES FIRST DATA FROM ONGOING DCVAX-DIRECT TRIAL "PR Newswire (US)" - 5/15/2014 8:00:00 AM
PRESENTATION ON NW BIO'S DCVAX-DIRECT TRIAL ANNOUNCED FOR ASCO ANNUAL MEETING "PR Newswire (US)" - 4/22/2014 8:15:00 AM
NW BIO CLOSES ON FIRST $15 MILLION OF FINANCING FOR SUBSTANTIAL EXPANSION OF EUROPEAN PRODUCTION CAPACITY "PR Newswire (US)" - 4/15/2014 1:11:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/14/2014 12:54:09 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 4/11/2014 5:21:38 PM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 15836 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist